Ignite Creation Date:
2024-05-05 @ 4:56 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00352677
Status:
COMPLETED
Last Update Posted:
2009-06-01
First Post:
2006-07-14
Brief Title:
Safety and Tolerability Study of INNO-406 to Treat Chronic Myeloid Leukemia or Acute Lymphocytic Leukemia
Sponsor:
CytRx
Organization:
CytRx
Organization Data
Organization:
CytRx
Class:
INDUSTRY
Study ID:
INNO-406
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
CytRx
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Michael Dowd Director Product Development
Old Organization:
Innovive Pharmaceuticals